Undergraduate education

University of Michigan, BS, 2005

Years in MSTP

2005-2014

PhD

Molecular and cellular pharmacology, 2012

Mentor

Ron Raines, PhD

Thesis title

Characterization and Exploitation of the Glycocalyx for Drug Delivery

Residency

Pathology, Harvard University, Medical School, 2014-2017

Fellowship

Broad Institute of MIT and Harvard, Center for the Science of Therapeutics, 2017-

Current position

Fellow, Department of Pathology, Brigham and Women's Hospital

PhD publications

Caes BR, Palte MJ, Raines RT. Organocatalytic conversion of cellulose into a platform chemical. Chemical Science. 2013 April; 4(1):196-199. PMID: 24596655; PMCID: PMC3939028.

Palte MJ, Davis AK, McGrath NA, Spiegel CA, Raines RT. Ribonucleoside 3'-phosphates as pro-moieties for an orally administered drug. ChemMedChem. 2012 Aug;7(8):1361-4. PMID: 22807330; PMCID: PMC3516917.

Palte MJ, Raines RT. Interaction of nucleic acids with the glycocalyx. J Am Chem Soc. 2012 Apr 11;134(14):6218-23. PMID: 22400897; PMCID: PMC3353769.

Lukesh JC 3rd, Palte MJ, Raines RT. A potent, versatile disulfide-reducing agent from aspartic acid. J Am Chem Soc. 2012 Mar 7;134(9):4057-9. PMID: 22353145; PMCID: PMC3353773. As featured in Chemical & Engineering News: A better disulfide reducing agent. 2012 Feb 29.

Ellis GA*, Palte MJ*, Raines RT. Boronate-mediated biologic delivery. J Am Chem Soc. 2012 Feb 29;134(8):3631-4: 22303837; PMCID: PMC3304437. (* Denotes equal contribution.) As featured in Nature, 484, 9(2012): Community Choice Highlight, Proteins’ ticket into the cell. As featured in Chemical & Engineering News: Drug Delivery Hooked on Sugar. 2012 Feb 15.

Ellis GA, McGrath NA, Palte MJ, Raines RT. Ribonuclease-Activated Cancer Prodrug. ACS Med Chem Lett. 2012 Feb 28;3(4):268-272. PMID: 22611478; PMCID: PMC3353771.